Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.81
+0.88 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for EW stock have an average target of 79.4, with a low estimate of 68 and a high estimate of 105. The average target predicts an increase of 6.14% from the current stock price of 74.81.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EW stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
Buy | 5 | 5 | 5 | 4 | 4 | 4 |
Hold | 11 | 11 | 13 | 13 | 13 | 12 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 20 | 22 | 21 | 21 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $82 → $90 | Hold → Strong Buy | Upgrades | $82 → $90 | +20.30% | Dec 16, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $81 → $83 | Strong Buy | Maintains | $81 → $83 | +10.95% | Dec 11, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $81 → $90 | Strong Buy | Maintains | $81 → $90 | +20.30% | Dec 5, 2024 |
Truist Securities | Truist Securities | Hold Reiterates $70 → $78 | Hold | Reiterates | $70 → $78 | +4.26% | Dec 5, 2024 |
Stifel | Stifel | Hold Maintains $70 → $75 | Hold | Maintains | $70 → $75 | +0.25% | Dec 5, 2024 |
Financial Forecast
Revenue This Year
5.95B
from 6.00B
Decreased by -0.86%
Revenue Next Year
6.01B
from 5.95B
Increased by 0.91%
EPS This Year
2.60
from 2.30
Increased by 12.91%
EPS Next Year
2.51
from 2.60
Decreased by -3.21%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 6.3B | 6.2B | 8.2B | |||
Avg | 6.0B | 6.0B | 6.6B | |||
Low | 5.3B | 5.6B | 6.1B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 4.3% | 4.8% | 36.3% | |||
Avg | -0.9% | 0.9% | 10.6% | |||
Low | -12.0% | -5.4% | 0.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 2.72 | 2.61 | 3.74 | |||
Avg | 2.60 | 2.51 | 2.85 | |||
Low | 2.09 | 2.28 | 2.53 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 18.2% | 0.7% | 48.7% | |||
Avg | 12.9% | -3.2% | 13.6% | |||
Low | -9.2% | -12.1% | 0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.